Refractory hypotension during paraganglioma removal - do we have to worry?
نویسندگان
چکیده
منابع مشابه
Do we have to worry for thrombocytopenia during treatment of hepatitis C.
bopag increases platelet numbers in thrombocytope-nic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy. Gastroenterology 2014; 146: 442-52. Thrombocytopenia is defined as platelet count being <150.000 cells/μL. A platelet count of 50.000 to 75.000/μL means moderate thrombocytopenia and a platelet count below 50.000 indicates severe throm-bocytopenia. It is com...
متن کاملWhy we do not have to worry about speaking the language of the computer
Communication is not the exchange of information If we are to believe the most optimistic predictions from the field of artificial intelligence, computers like HAL in 2001 will speak our language so we will not have to speak theirs. That would be an ideal state of affairs. Since we have to deal with computers, it would be convenient if we could talk to them in ordinary language. But that is not...
متن کاملWhy we (usually) don’t have to worry about multiple comparisons
Applied researchers often find themselves making statistical inferences in settings that would seem to require multiple comparisons adjustments. We challenge the Type I error paradigm that underlies these corrections. Moreover we posit that the problem of multiple comparisons can disappear entirely when viewed from a hierarchical Bayesian perspective. We propose building multilevel models in th...
متن کاملDo we have to hyperventilate during laparoscopic surgery?
PURPOSE The purpose of this study was to assess the effects of hyperventilation on patients undergoing laparoscopic surgeries on haemodynamics, partial pressure of carbon dioxide and acid base status. METHODS 60 patients undergoing laparoscopic surgeries under General Anaesthesia were randomized into two groups, "control group" ventilated with tidal volume of 10 ml/kg and respiratory rate of ...
متن کاملTicagrelor therapy and atrioventricular block: Do we need to worry?
Ticagrelor is a potent, direct P2Y12 antagonist with rapid onset of action and intense platelet inhibition, indicated in patients with acute coronary syndromes (ACS). This drug is usually well tolerated, but some patients experience serious adverse effects: Major bleeding; gastrointestinal disturbances; dyspnoea; ventricular pauses > 3 s. Given the unexpected high incidence of bradyarrhythmias,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Anaesthesia
سال: 2016
ISSN: 0019-5049
DOI: 10.4103/0019-5049.187817